Anthracyclines: the first generation of cytotoxic targeted agents? A possible dream
- PMID: 18768431
- DOI: 10.1200/JCO.2008.18.3137
Anthracyclines: the first generation of cytotoxic targeted agents? A possible dream
Comment on
-
Type 1 receptor tyrosine kinase profiles identify patients with enhanced benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial.J Clin Oncol. 2008 Nov 1;26(31):5027-35. doi: 10.1200/JCO.2007.14.6597. Epub 2008 Sep 2. J Clin Oncol. 2008. PMID: 18768436 Clinical Trial.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
